Literature DB >> 25231192

TGFβ and Wnt in cardiac outflow tract defects in offspring of diabetic pregnancies.

Zhiyong Zhao1.   

Abstract

BACKGROUND: Diabetes mellitus in pregnancy causes defects in infant heart, including the outflow tracts (OFTs). Development of the aorta and pulmonary artery, which are derived from the common OFT in the embryo, is regulated by the transforming growth factor β (TGFβ) and Wnt families, and can be perturbed by hyperglycemia-generated intracellular stress conditions. However, the underlying cellular and molecular mechanisms remain to be delineated.
METHODS: Female mice were induced diabetic with streptozotocin. Embryonic and fetal OFTs were examined morphologically and histologically. Cell proliferation was assessed using 5'-bromo-2'-deoxyuridine incorporation assay. Oxidative and endoplasmic reticulum (ER) stress markers and TGFβ factors were detected using immunohistochemistry. The expression of genes in the Wnt-signaling system was assessed using real-time reverse transcription polymerase chain reaction array. The role of activin-A in cell proliferation was addressed by treating embryos cultured in high glucose with activin-A.
RESULTS: Maternal diabetes caused complex abnormalities in the OFTs, including aortic and pulmonary stenosis and persistent truncus arteriosus. The development of the endocardial cushions was suppressed, manifested with insufficient cellularization of the tissues. Cell proliferation was significantly decreased under oxidative and ER stress conditions. The expression of genes in the Wnt signaling was significantly altered. Activin-A and Smad3 were found to be expressed in the OFT. Treatment with activin-A rescued cell proliferation in the endocardial cushions.
CONCLUSIONS: Maternal diabetes generates oxidative and ER stress conditions, suppresses TGFβ and Wnt signaling, inhibits cell proliferation and cellularization of the endocardial cushions, leading to OFT septal defects. Activin-A plays a role in hyperglycemia-suppressed proliferation of the endocardial cells.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  TGFβ; Wnt; cardiac defects; diabetic embryopathy; outflow tract

Mesh:

Substances:

Year:  2014        PMID: 25231192      PMCID: PMC4372991          DOI: 10.1002/bdrb.21120

Source DB:  PubMed          Journal:  Birth Defects Res B Dev Reprod Toxicol        ISSN: 1542-9733


  37 in total

Review 1.  Controlling TGF-beta signaling.

Authors:  J Massagué; Y G Chen
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

Review 2.  Cell biology of cardiac development.

Authors:  M J Farrell; M L Kirby
Journal:  Int Rev Cytol       Date:  2001

Review 3.  Septation and separation within the outflow tract of the developing heart.

Authors:  Sandra Webb; Sonia R Qayyum; Robert H Anderson; Wouter H Lamers; Michael K Richardson
Journal:  J Anat       Date:  2003-04       Impact factor: 2.610

Review 4.  Neural crest migration and mouse models of congenital heart disease.

Authors:  A D Gitler; C B Brown; L Kochilas; J Li; J A Epstein
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2002

Review 5.  Development of the heart: (3) formation of the ventricular outflow tracts, arterial valves, and intrapericardial arterial trunks.

Authors:  Robert H Anderson; Sandra Webb; Nigel A Brown; Wouter Lamers; Antoon Moorman
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

6.  Isolation and culture of whole postimplantation embryos and germ layer derivatives.

Authors:  K Sturm; P P Tam
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

7.  Cardiovascular malformations in infants of diabetic mothers.

Authors:  C Wren; G Birrell; G Hawthorne
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

8.  Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus.

Authors:  C Ferencz; J D Rubin; R J McCarter; E B Clark
Journal:  Teratology       Date:  1990-03

9.  Malformations in infants of diabetic mothers.

Authors:  J L Mills
Journal:  Teratology       Date:  1982-06

10.  N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes.

Authors:  Hoda Moazzen; Xiangru Lu; Noelle L Ma; Thomas J Velenosi; Brad L Urquhart; Lambertus J Wisse; Adriana C Gittenberger-de Groot; Qingping Feng
Journal:  Cardiovasc Diabetol       Date:  2014-02-18       Impact factor: 9.951

View more
  6 in total

1.  Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.

Authors:  Sribalasubashini Muralimanoharan; Cun Li; Ernesto S Nakayasu; Cameron P Casey; Thomas O Metz; Peter W Nathanielsz; Alina Maloyan
Journal:  J Mol Cell Cardiol       Date:  2017-06-19       Impact factor: 5.000

2.  Long-noncoding RNA HOXA transcript at the distal tip ameliorates the insulin resistance and hepatic gluconeogenesis in mice with gestational diabetes mellitus via the microRNA-423-5p/wingless-type MMTV integration site family member 7A axis.

Authors:  Qianqian Cao; Xiaojie Zhang; Fengfeng Xie; Yangping Li; Feng Lin
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  In ovo hyperglycemia causes congenital limb defects in chicken embryos via disruption of cell proliferation and apoptosis.

Authors:  Zehuan Ding; Huijuan Zhou; Naomi McCauley; Gladys Ko; Ke K Zhang; Linglin Xie
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-08-30       Impact factor: 5.187

Review 4.  WNT signaling in atrial fibrillation.

Authors:  Carmen Wolke; Elmer Antileo; Uwe Lendeckel
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-27

Review 5.  The role of glucose in physiological and pathological heart formation.

Authors:  Haruko Nakano; Viviana M Fajardo; Atsushi Nakano
Journal:  Dev Biol       Date:  2021-02-10       Impact factor: 3.148

6.  Downregulation of hsa_circ_0005243 induces trophoblast cell dysfunction and inflammation via the β-catenin and NF-κB pathways.

Authors:  Huiyan Wang; Wenbo Zhou; Guangtong She; Bin Yu; Lizhou Sun
Journal:  Reprod Biol Endocrinol       Date:  2020-05-20       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.